Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1952 1
1953 1
1956 1
1966 1
1969 1
1970 4
1972 2
1973 3
1974 2
1975 1
1977 1
1978 2
1979 2
1980 4
1981 2
1982 2
1984 4
1985 7
1986 5
1987 8
1988 6
1989 4
1990 12
1991 3
1992 9
1993 6
1994 3
1995 4
1996 11
1997 4
1998 4
1999 10
2000 4
2001 6
2002 9
2003 8
2004 7
2005 7
2006 13
2007 8
2008 13
2009 10
2010 13
2011 16
2012 19
2013 21
2014 26
2015 22
2016 14
2017 22
2018 34
2019 29
2020 46
2021 57
2022 55
2023 66
2024 37

Text availability

Article attribute

Article type

Publication date

Search Results

582 results

Results by year

Filters applied: . Clear all
Page 1
Female Androgenetic Alopecia: An Update on Diagnosis and Management.
Starace M, Orlando G, Alessandrini A, Piraccini BM. Starace M, et al. Am J Clin Dermatol. 2020 Feb;21(1):69-84. doi: 10.1007/s40257-019-00479-x. Am J Clin Dermatol. 2020. PMID: 31677111 Review.
Female androgenetic alopecia (FAGA) is a common cause of non-scarring alopecia in women. ...The goal of therapy is to stop the progression and to induce a cosmetically acceptable hair regrowth. ...
Female androgenetic alopecia (FAGA) is a common cause of non-scarring alopecia in women. ...The goal of therapy …
A review of the treatment of male pattern hair loss.
York K, Meah N, Bhoyrul B, Sinclair R. York K, et al. Expert Opin Pharmacother. 2020 Apr;21(5):603-612. doi: 10.1080/14656566.2020.1721463. Epub 2020 Feb 17. Expert Opin Pharmacother. 2020. PMID: 32066284 Review.
Introduction: Androgenetic alopecia is a common hair loss disorder affecting up to 80% of males by the age of 80. ...An effective treatment for hair baldness is needed.Areas covered: In androgenetic alopecia, hair follicles undergo progressive miniatur …
Introduction: Androgenetic alopecia is a common hair loss disorder affecting up to 80% of males by the age of 80. ...An effect …
European expert consensus statement on the systemic treatment of alopecia areata.
Rudnicka L, Arenbergerova M, Grimalt R, Ioannides D, Katoulis AC, Lazaridou E, Olszewska M, Ovcharenko YS, Piraccini BM, Prohic A, Rakowska A, Reygagne P, Richard MA, Soares RO, Starace M, Vañó-Galvan S, Waskiel-Burnat A. Rudnicka L, et al. J Eur Acad Dermatol Venereol. 2024 Apr;38(4):687-694. doi: 10.1111/jdv.19768. Epub 2024 Jan 2. J Eur Acad Dermatol Venereol. 2024. PMID: 38169088 Review.
The disease severity evaluation tools used in clinical practice are: the Severity of Alopecia Tool (SALT) score and the Alopecia Areata Scale (AAS). A SALT score equal to or greater than 20 constitutes a commonly accepted indication for systemic therapy in …
The disease severity evaluation tools used in clinical practice are: the Severity of Alopecia Tool (SALT) score and the Alopecia …
Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men - short version.
Kanti V, Messenger A, Dobos G, Reygagne P, Finner A, Blumeyer A, Trakatelli M, Tosti A, Del Marmol V, Piraccini BM, Nast A, Blume-Peytavi U. Kanti V, et al. J Eur Acad Dermatol Venereol. 2018 Jan;32(1):11-22. doi: 10.1111/jdv.14624. Epub 2017 Nov 27. J Eur Acad Dermatol Venereol. 2018. PMID: 29178529
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. ...The purpose of the guideline is to provide dermatologists with an evidence-based tool for choosing an efficacious and safe therapy for patients with androgenetic …
Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. ...The purpose of the guideline is …
Relative Efficacy of Minoxidil and the 5-alpha Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
Gupta AK, Venkataraman M, Talukder M, Bamimore MA. Gupta AK, et al. JAMA Dermatol. 2022 Mar 1;158(3):266-274. doi: 10.1001/jamadermatol.2021.5743. JAMA Dermatol. 2022. PMID: 35107565 Free PMC article.
IMPORTANCE: There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), namely, minoxidil and the two 5-alpha reductase inhibitors dutasteride and finasteride. ...The greatest increase in total hair count at 24 …
IMPORTANCE: There are knowledge gaps regarding the relative efficacy of 3 commonly used drugs for androgenetic alopecia (AGA), …
Autoimmune polyendocrine syndrome type 1: Clinical manifestations, pathogenetic features, and management approach.
Bjørklund G, Pivin M, Hangan T, Yurkovskaya O, Pivina L. Bjørklund G, et al. Autoimmun Rev. 2022 Aug;21(8):103135. doi: 10.1016/j.autrev.2022.103135. Epub 2022 Jun 9. Autoimmun Rev. 2022. PMID: 35690244 Review.
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine and non-endocrine manifestations in childhood. ...APS-1 is often accompanied by hypogonadism, type 1 diabetes, autoimmune thyro …
Autoimmune polyendocrine syndrome type 1 (APS-1) is an autosomal recessive hereditary pathology that develops with endocrine a …
Topical ketoconazole for the treatment of androgenetic alopecia: A systematic review.
Fields JR, Vonu PM, Monir RL, Schoch JJ. Fields JR, et al. Dermatol Ther. 2020 Jan;33(1):e13202. doi: 10.1111/dth.13202. Epub 2020 Jan 2. Dermatol Ther. 2020. PMID: 31858672
Androgenetic alopecia (AGA) is common and associated with significant psychosocial distress. ...Topical ketoconazole is a promising adjunctive or alternative therapy in the treatment of AGA. Randomized controlled trials are needed....
Androgenetic alopecia (AGA) is common and associated with significant psychosocial distress. ...Topical ketoconazole is a prom …
Medical Treatment for Androgenetic Alopecia.
Panchaprateep R. Panchaprateep R. Facial Plast Surg. 2024 Apr;40(2):252-266. doi: 10.1055/a-2196-4713. Epub 2023 Oct 23. Facial Plast Surg. 2024. PMID: 37871637
Androgenetic alopecia is a common type of hair loss, which is generally influenced by genetic factors and systemic androgens resulting in follicular miniaturization.1 It can cause cosmetic problems leading to psychological distress among affected men and wome …
Androgenetic alopecia is a common type of hair loss, which is generally influenced by genetic factors and systemic androgens r …
Guidelines for the diagnosis and treatment of male-pattern and female-pattern hair loss, 2017 version.
Manabe M, Tsuboi R, Itami S, Osada SI, Amoh Y, Ito T, Inui S, Ueki R, Ohyama M, Kurata S, Kono T, Saito N, Sato A, Shimomura Y, Nakamura M, Narusawa H, Yamazaki M; Drafting Committee for the Guidelines for the Diagnosis and Treatment of Male- and Female-Pattern Hair Loss. Manabe M, et al. J Dermatol. 2018 Sep;45(9):1031-1043. doi: 10.1111/1346-8138.14470. Epub 2018 Jun 4. J Dermatol. 2018. PMID: 29863806
Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after puberty. ...Thus, here we report a revised version of the 2010 guidelines aimed at both MPHL and FPHL. In these guidelines, finasteride 1 m …
Male-pattern hair loss (MPHL, androgenetic alopecia) is a slowly progressive form of alopecia which begins after pubert …
582 results